BackBeijing Chunlizhengda Medical Instruments , Ltd. Overview

Beijing Chunlizhengda Medical Instruments , Ltd. Intangible Assets

Track Beijing Chunlizhengda Medical Instruments , Ltd.'s intangible assets ($110M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$114.96M
↓ 7.97% YoYΔ $-9.96M vs prior year quarter

Peer trimmed avg / median

Loading

Beijing Chunlizhengda Medical Instruments , Ltd. Intangible Assets History

Loading

Beijing Chunlizhengda Medical Instruments , Ltd. vs. peers: Intangible Assets Comparison

Loading

Beijing Chunlizhengda Medical Instruments , Ltd. Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Beijing Chunlizhengda Medical Instruments , Ltd. (688236.SS) FAQ

The latest intangible assets for 688236.SS is $110M as of June 2026. That compares with $120M in the prior-year period — down 8.0% year over year. Investors often review this figure alongside Beijing Chunlizhengda Medical Instruments , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 688236.SS's intangible assets moved from $120M to $110M — a 8.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Beijing Chunlizhengda Medical Instruments , Ltd.'s operating scale or balance-sheet position.

A intangible assets figure of $110M for 688236.SS is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 688236.SS's intangible assets ($110M), review year-over-year change from $120M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.